A comparison of albumin,polygeline and crystalloid priming solutions for cardiopulmonary bypass in patients having coronary artery bypass graft surgery

Abstract

This study was designed to assess the effect of different prime solution compositions on a patient's fluid balance, transfusion requirements, renal function and haemodynamic stability over the first 24 hours postbypass. Ninety-three patients presenting for first-time coronary artery bypass graft (CABG) surgery were randomly allocated to receive one of three prime solutions for the CPB pump: albumin (4.6%) + Plasmalyte (Group A, n = 32), polygeline (Hemaccel) + Plasmalyte (Group P, n = 29), or crystalloid (Plasmalyte) alone (Group C, n = 32). Patients, anaesthetists, surgeons and intensive care unit (ICU) staff were all blinded as to the solution type.

The groups were demographically and haemodynamically similar. There were no differences between the groups with respect to white cell or platelet counts during the study. There was a significant difference in haemoglobin levels between the groups on weaning from CPB and on arrival in the ICU (Group C > Groups P and A, p < 0.001 for both times). There was no difference in blood transfusion requirements between any of the groups. During CPB, Group C required significantly more crystalloid than the other groups (p < 0.001). Urine output was significantly higher in Group C compared with Groups P and A at all time periods up to and including ICU 12 hours (p < 0.05). The use of frusemide was significantly higher in the ICU in Groups P and A (p < 0.01). There was a net gain of 3132 ± 412 ml in Group C in 24 hour fluid balance, which was significantly higher than Group A (2166 ± 223 ml, p = 0.04). Our results show that, in this patient population, there is no advantage in using a colloid-based prime solution over a purely crystalloid solution from a haemotologic or haemodynamic point of view for the first 24 hours after CPB. There appears to be an increase in extracellular fluid (ECF) retention in Group C, but this caused no related problems in the study period. On the other hand, diuretics (frusemide) needed to be given significantly less often in these patients to offset oliguria.

References

Ohri SK The effects of cardiopulmonary bypass on the immune system. Perfusion 1993; 8 : 121-37.

Sanchez de Leon R. , Paterson JL , Sykes MK Changes in colloid osmotic pressure and plasma albumin concentration associated with extracorporeal circulation. Br J Anaesth 1982; 54 : 465-73.

Byrick RJ , Colin JC , Noble WH Extravascular lung water accumulation in patients following coronary artery surgery. Can J Anaesth 1977 ; 24: 332-45.

Lumb PD A comparison between 25% albumin and 6% hydroxyethyl starch solutions on lung water accumulation during and immediately after cardiopulmonary bypass . Ann Surg 1987; 206: 210-13.

Hoeft A. , Korb H. , Mehlhorn U. , Stephan H. , Sonntag H. Priming of cardiopulmonary bypass with human albumin or Ringer lactate: effect on colloid osmotic pressure and extravascular lung water. Br J Anaesth 1991;66 : 73-80.

Laks H. , Standeven J. , Blair O. , Hahn J. , Jellinek M. , Willman VL The effects of cardiopulmonary bypass with crystalloid and colloid hemodilution on myocardial extravascular water. J Thorac Cardiovasc Surg 1977; 73 : 129-38.

Roohk HV , Pick J. , Hill R. , Hung E. , Barlett RH Kinetics of fibrinogen and platelet adherence to biomaterials. Trans Am Soc Artif Int Organs 1976; xxii: 1-7.

Marelli D. , Paul A. , Samsom R. , Edgell D. , Angood P. , Chiu R.

Does the addition of albumin to the prime solution in cardiopulmonary bypass affect clinical outcome?

J Thorac Cardiovasc Surg 1989; 98: 751-56.

Sandrelli L. , Alfieri O. , van Oeveren W. The problem of priming solutions? The solution of priming problems. Perfusion 1992 ; 7 : 217-21.

10.

Greer AE , Carey JM , Zudhi. Haemodilution principle of hypothermic perfusion: A concept obviating blood priming. J Thorac Cardiovasc Surg 1962; 43: 640-48.

11.

Hett DA Smith DC A survey of priming solutions used for cardiopulmonary bypass. Perfusion 1994; 9 : 19-22.

12.

Stein L. , Beraud JJ , Messerette M. et al. Pulmonary edema during volume infusion. Circulation 1975; 52 : 483-89.

13.

Sade RM , Stroud RM , Crawford FA , Kratz JM , Dearing JP , Bartles DM A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass . J Thorac Cardiovasc Surg 1985; 89: 713-22.

14.

Himpe D. , Van Cauwelaert P. , Neels H. et al . Priming solutions for cardiopulmonary bypass: Comparison of three colloids. J Cardiothorac Vasc Anesth 1991; 5: 457-66.

15.

Hussain SF , Drew Pjt. Acute renal failure after infusion of gelatins. Br Med J 1989; 299 : 1137-38.

16.

Ramsy G. Intravenous volume replacement: indications and choices. Br Med J 1988; 296 : 1422-23.

17.

Cottier P. , Basevi A. , Schafroth HJ The effect upon the function of the kidneys of the gelatin plasma expander Gelofusin. Helv Chir Acta 1966; 33: 383-91.

18.

Van Der Starre P. , Sinclair D. , Damen J. , Brummelhuis H. Inhibition of the hypotensive effect of plasma protein solutions by C-1-esterase inhibitor . J Thorac Cardiovasc Surg 1980; 79: 738-40.

19.

Bonser RS , Dave JR , Davies ET et al . Reduction of complement activation during bypass by prime manipulation . Ann Thorac Surg 1990; 49: 279-83.